Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - OtherWages, Salaries and Other
Ratios

Capricor Therapeutics (CAPR) Receivables - Net (2023 - 2024)

Capricor Therapeutics has reported Receivables - Net over the past 3 years, most recently at $10.0 million for Q4 2024.

  • Quarterly results put Receivables - Net at $10.0 million for Q4 2024, changed 0.0% from a year ago — trailing twelve months through Dec 2024 was $10.0 million (changed 0.0% YoY), and the annual figure for FY2024 was $10.0 million, changed 0.0%.
  • Receivables - Net for Q4 2024 was $10.0 million at Capricor Therapeutics, roughly flat from $10.0 million in the prior quarter.
  • Over the last five years, Receivables - Net for CAPR hit a ceiling of $10.0 million in Q4 2023 and a floor of $10.0 million in Q4 2023.